Drug discovery today

Drug Discov Today · ISSN (e) 1878-5832 · 5 papers in corpus
review 2025
doi:10.1016/j.drudis.2025.104519 ·PMID:41167388

Endometrial cyclic remodeling and decidualization are critical physiological processes for female reproductive function and are profoundly influenced by mitochondrial homeostasis. Mitochondrial homeostasis is maintained through the mitochon…

review 2021
doi:10.1016/j.drudis.2021.11.010 ·PMID:34775103

Endometrial disorders collectively encompass a broad spectrum of pathologies, including but not limited to endometriosis, endometrial cancer and endometritis. The current therapeutic management of these diseases is associated with several l…

review 2020
doi:10.1016/j.drudis.2020.06.013 ·PMID:32562843

Here, we highlight recent findings on the urokinase plasminogen activator (uPA)/uPA receptor (uPAR) system that suggest its potential role as a main orchestrator of fatal progression to pulmonary, kidney, and heart failure in patients with …

review 2016
doi:10.1016/j.drudis.2015.10.012 ·PMID:26526566

Antibody-cytokine fusion proteins, often referred to as immunocytokines, represent a novel class of biopharmaceutical agents that combine the disease-homing activity of certain antibodies with the immunomodulatory properties of cytokine pay…

review 2012
doi:10.1016/j.drudis.2011.10.024 ·PMID:22056715

The general goal of drug discovery is to identify novel compounds that are active against a preselected biological target with acceptable pharmacological properties defined by marketed drugs. Scaffold hopping has been widely applied by medi…